Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Bausch pays whopping $300M to settle diabetes antitrust dispute
Bausch pays whopping $300M to settle diabetes antitrust dispute
Bausch Health, which industry watchers may remember by its former name Valeant, has been riddled in controversy for years over its defense of diabetes med Glumetza.
From Pfizer to Argenx: A look at potential blockbusters awaiting FDA decisions this year
From Pfizer to Argenx: A look at potential blockbusters awaiting FDA decisions this year
This year has already witnessed a handful of memorable FDA approvals.
France's Sanofi to buy U.S. biopharma firm Kadmon in $1.9 bln deal
France's Sanofi to buy U.S. biopharma firm Kadmon in $1.9 bln deal
PARIS, Sept 9 (Reuters) - French drugmaker Sanofi (SASY.
FDA-approved gout medicine could also battle COVID-19
FDA-approved gout medicine could also battle COVID-19
Probenecid is already FDA approved and has potent antiviral properties against SARS-CoV-2As COVID-19 cases continue to skyrocket across the U.
AstraZeneca reports positive data from PT027 fixed-dose combination trials
AstraZeneca reports positive data from PT027 fixed-dose combination trials
AstraZeneca has reported positive high-level data from Phase III MANDALA and DENALI clinical trials of its combination treatment, PT027, in asthma patients.
A new collaboration deal with Eli Lilly could be worth up to $1.3 billion
A new collaboration deal with Eli Lilly could be worth up to $1.3 billion
Shares of ProQR Inc.
EnGeneIC initiates Phase I trial of nanocellular anti-Covid-19 vaccine
EnGeneIC initiates Phase I trial of nanocellular anti-Covid-19 vaccine
EnGeneIC has initiated dosing in Phase I clinical trial of its first-ever nanocellular technology-based anti-Covid-19 vaccine in healthy adults.
Sandoz strengthens pipeline by entering into agreement for biosimilar bevacizumab, a key oncology medicine
Sandoz strengthens pipeline by entering into agreement for biosimilar bevacizumab, a key oncology medicine
Basel, September 8, 2021 — Sandoz, a Novartis division, today announced that it has entered into a commercialization agreement with Bio-Thera Solutions, Ltd.
FDA Grants Empagliflozin Breakthrough Therapy Designation in HFpEF
FDA Grants Empagliflozin Breakthrough Therapy Designation in HFpEF
The sodium glucose co-transporter 2 (SGLT2) inhibitor reduced cardiovascular death and hospitalization for heart failure by 21% in results presented August 27 during the recent European So...
Eloxx Pharmaceuticals Gets FDA Fast Track Designation for ELX-02 in Cystic Fibrosis
Eloxx Pharmaceuticals Gets FDA Fast Track Designation for ELX-02 in Cystic Fibrosis
Eloxx Pharmaceuticals Inc.
VOR33 Granted U.S. FDA Fast Track Designation for AML
VOR33 Granted U.S. FDA Fast Track Designation for AML
CAMBRIDGE, Mass.
U.S. FDA declines emergency use approval for Humanigen's COVID-19 drug
U.S. FDA declines emergency use approval for Humanigen's COVID-19 drug
Sept 9 (Reuters) - The U.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand